Robert W Postma - 11 Apr 2025 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
11 Apr 2025
Net transactions value
+$62,128
Form type
4
Filing time
15 Apr 2025, 20:42:09 UTC
Previous filing
10 Jun 2024
Next filing
26 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Award $60,748 +20,804 +251% $2.92 29,083 13 Apr 2025 Direct
holding TCRT Common Stock 24 11 Apr 2025 By spouse's IRA
holding TCRT Common Stock 33,333 11 Apr 2025 By WaterMill Asset Management Corp. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Series A-1 Convertible Preferred Stock Purchase $1,380 +500 $2.76 500 11 Apr 2025 Common Stock 181,159 $2.76 By WaterMill Asset Management Corp. F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.
F2 The preferred stock is perpetual and therefore has no expiration date.
F3 The reporting person disclaims beneficial ownership of these equity securities to the extent that after giving effect of the conversion of the preferred stock and the underlying common stock issuance, the reporting person would beneficially own in the aggregate in excess of 4.99% of the outstanding shares immediately after giving effect to such conversion or issuance.